Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

97.26 -0.46 (-0.47%)

Streaming Delayed Price Updated: 3:56 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Boston Scientific Beefs Up Electrophysiology, Structural Heart Portfolio With $1.75B Baylis Deal ↗

October 06, 2021

Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Baylis Medical Company Inc for an upfront payment of $1.75 billion. The acquisition will...

Via Benzinga

Boston Scientific Highlights Trial Data For EkoSonic System For Pulmonary Embolism ↗

October 06, 2021

Boston Scientific Corporation (NYSE: BSX) announced results for the EkoSonic Endovascular System at the Vascular InterVentional Advances (VIVA) meeting. ...

Via Benzinga

FDA Takes Note Of Higher Risk For Women With Stroke-Preventing Implants ↗

September 29, 2021

The FDA informed health care providers of the potential for differences in procedural outcomes between women and men undergoing implant of a left atrial appendage...

Via Benzinga

Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices

September 21, 2021

Via FinancialNewsMedia

Where Boston Scientific Stands With Analysts ↗

August 21, 2021

Within the last quarter, Boston Scientific (NYSE:BSX) has ob...

Via Benzinga

Unusual Options Activity Insight: Boston Scientific ↗

August 10, 2021

On Tuesday, shares of Boston Scientific (NYSE:BSX) saw unusu...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Boston Scientific Acquires Provider Of Thrombectomy Platform In Over $300M Deal ↗

September 21, 2021

Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Devoro Medical Inc for over 300 million. Boston Scientific has been a strategic investor in...

Via Benzinga

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data ↗

September 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...

Via Benzinga

Why Boston Scientific Shares Are Trading Higher Today ↗

July 27, 2021

Boston Scientific (NYSE:BSX) shares are trading higher after ...

Via Benzinga

Earnings Scheduled For July 27, 2021 ↗

July 27, 2021

Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million....

Via Benzinga

Boston Scientific Posts Colorectal Cancer Survival Data For Tumor-Targeting Microbeads ↗

September 20, 2021

Boston Scientific Corporation (NYSE: BSX) announced that the EPOCH clinical trial of the TheraSphere Y-90 Glass Microspheres (TheraSphere treatment) met both primary...

Via Benzinga

'Fast Money Halftime Report' Picks For September 15 ↗

September 15, 2021

On CNBC's "Fast Money Halftime Report," Karen Firestone said Charles Schwab (NYSE: SCHW) has a lot of new young traders who have larger accounts than Robinhood...

Via Benzinga

Abbott Says Amulet Superior To Boston Scientific's Watchman In Stroke Study ↗

August 30, 2021

Abbott Laboratories (NYSE: ABT) has announced late-breaking data from the Amulet LAA Occluder IDE trial. The head-to-head study compared Abbott's Amplatzer...

Via Benzinga

Post Market Studies Reinforce Unfavorable Risk-Benefit Profile For Boston Scientific's Vaginal Mesh ↗

August 17, 2021

Final results from postmarket surveillance studies of Boston Scientific Corporation's (NYSE: BSX) transvaginal mesh for pelvic organ prolapse (POP) have reinforced...

Via Benzinga

Boston Scientific's Exalt Model B Single-Use Bronchoscope Wins FDA Approval ↗

August 11, 2021

The FDA has given 510(k) clearance for Boston Scientific Corp's (NYSE: BSX) Exalt Model B single-use bronchoscope for use in bedside procedures within the intensive...

Via Benzinga

Boston Scientific Recalls Faulty Pacemakers Due To Risk of Incorrect Transition To Safety Mode ↗

August 06, 2021

Boston Scientific Corporation (NYSE: BSX) is recalling Ingenio family pacemakers or cardiac resynchronization therapy pacemakers (CRT-Ps) devices due to the risk of...

Via Benzinga

Topics Product Recall

Boston Scientific Starts Trial For EkoSonic Endovascular System In Patients With Pulmonary Embolism ↗

August 04, 2021

Boston Scientific Corporation (NYSE: BSX) began enrollment for a clinical trial of its EkoSonic endovascular system (EKOS). Boston Scientific’s HI-PEITHO...

Via Benzinga

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business ↗

August 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

'Fast Money Halftime Report' Picks For July 30 ↗

July 30, 2021

On CNBC's "Fast Money Halftime Report," Shannon Saccocia picked salesforce.com, inc. (NYSE: CRM) as her final trade. The company is going to report earnings in few...

Via Benzinga

Stock Market Rally Pauses Near Highs Amid Earnings From Apple, Microsoft, Tesla, Amazon, Google, Facebook ↗

July 30, 2021

The market rally paused on the key indexes amid earnings from Apple, Tesla and Amazon. But several stocks flashed buy signals.

Via Investor's Business Daily

Topics Economy Stocks

Boston Scientific Corp (BSX) Q2 2021 Earnings Call Transcript ↗

July 27, 2021

BSX earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Boston Scientific Earnings Top; BSX Stock Just Below Buy Point ↗

July 27, 2021

Boston Scientific earnings and revenue beat Q2 views for the medtech giant. BSX stock rose to just below a buy point.

Via Investor's Business Daily

Boston Scientific Earnings Exceed Expectations As Demand Picks Up, Raises FY21 Guidance ↗

July 27, 2021

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.1 billion in Q2 of 2021, beating the estimate of $2.9 billion. Sales increased 53.6% Y/Y on a...

Via Benzinga

Recap: Boston Scientific Q2 Earnings ↗

July 27, 2021

Shares of Boston Scientific (NYSE:BSX) fell 1.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 400.00% year...

Via Benzinga

Unusual Options Activity Insight: Boston Scientific ↗

July 01, 2021

Boston Scientific (NYSE:BSX) shares experienced unusual options activity on Thursday. The stock price moved up to $43.24 following the option alert. Sentiment: BULLISH Option...

Via Benzinga

Understanding Boston Scientific's Unusual Options Activity ↗

June 30, 2021

Shares of Boston Scientific (NYSE:BSX) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $42.7. Sentiment:...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

July 27, 2021

This morning 85 companies set new 52-week highs. Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG). Intec...

Via Benzinga

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗

July 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Boston Scientific (NY:BSX)

All News about Boston Scientific

Starting at $3.75/week.

Subscribe Today